{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:39:11Z","timestamp":1790357951994,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.atherosclerosis.2011.01.028","type":"journal-article","created":{"date-parts":[[2011,1,27]],"date-time":"2011-01-27T09:24:00Z","timestamp":1296120240000},"page":"131-138","source":"Crossref","is-referenced-by-count":29,"title":["Association of haptoglobin genotype and common cardiovascular risk factors with the amount of iron in atherosclerotic carotid plaques"],"prefix":"10.1016","volume":"216","author":[{"given":"Christos","family":"Lioupis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calypso","family":"Barbatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggeliki","family":"Drougou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Koliaraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avgi","family":"Mamalaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Klonaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Georgopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilios","family":"Andrikopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Bastounis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0005","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1161\/01.ATV.0000057807.28754.7F","article-title":"Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis","volume":"23","author":"Kockx","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0010","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.ATV.0000178991.71605.18","article-title":"Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage","volume":"25","author":"Virmani","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2174\/156652406778018626","article-title":"Intraplaque hemorrhage","volume":"6","author":"Levy","year":"2006","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0020","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2004.07.060","article-title":"New aspects in the pathogenesis of diabetic atherothrombosis","volume":"44","author":"Moreno","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0025","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0741-5214(99)70136-9","article-title":"Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphology","volume":"30","author":"McCarthy","year":"1999","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0030","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0002-8703(98)70144-9","article-title":"When neoangiogenesis ricochets","volume":"136","author":"Virmani","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0035","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0040","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jacc.2008.06.029","article-title":"Haptoglobin genotype is a major determinant of the amount of iron in the human atherosclerotic plaque","volume":"52","author":"Moreno","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0045","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM199108153250701","article-title":"Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.atherosclerosis.2011.01.028_bib0050","first-page":"157","article-title":"Correlation of North American Symptomatic Carotid Endarterectomy Trial (NASCET) angiographic definition of 70\u201399% internal carotid artery stenosis with duplex scanning","volume":"152\u2013157","author":"Moneta","year":"1993","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0055","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/01.CIR.0000138103.91187.E3","article-title":"Carotid plaque echolucency increases the risk of stroke in carotid stenting: the Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) study","volume":"110","author":"Biasi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0060","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ahj.2004.12.023","article-title":"Carotid plaque composition in stable and unstable coronary artery disease","volume":"150","author":"Triposkiadis","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0065","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/01.ATV.20.5.1177","article-title":"Natural history and histological classification of atherosclerotic lesions: an update","volume":"20","author":"Stary","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0070","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1182\/blood.V98.13.3693","article-title":"Structure\u2013function analysis of the anti-oxidant properties of haptoglobin","volume":"98","author":"Frank","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0075","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.RES.0000076889.23082.F1","article-title":"Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease","volume":"92","author":"Asleh","year":"2003","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2011.01.028_bib0080","first-page":"184","article-title":"Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation","volume":"189\u2013261","author":"Bowman","year":"1982","journal-title":"Adv Hum Genet"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0085","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0021-9150(01)00657-8","article-title":"Haptoglobin phenotype and coronary artery collaterals in diabetic patients","volume":"161","author":"Hochberg","year":"2002","journal-title":"Atherosclerosis"},{"issue":"Pt 5","key":"10.1016\/j.atherosclerosis.2011.01.028_bib0090","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/000456329903600507","article-title":"A new method for haptoglobin phenotyping","volume":"36","author":"Wassell","year":"1999","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0095","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/clinchem\/48.9.1377","article-title":"Genotyping of the common haptoglobin Hp 1\/2 polymorphism based on PCR","volume":"48","author":"Koch","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCRESAHA.107.149435","article-title":"Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype: implications for the response to intraplaque hemorrhage and plaque vulnerability","volume":"101","author":"Levy","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2009.06.021","article-title":"The haptoglobin 2-2 genotype is associated with increased redox active hemoglobin derived iron in the atherosclerotic plaque","author":"Kalet-Litman","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0110","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease","volume":"293","author":"Rother","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0115","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0120","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI18127","article-title":"Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells","volume":"112","author":"Du","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0125","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1161\/01.CIR.0000017265.52501.37","article-title":"Intimomedial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability","volume":"105","author":"Moreno","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0021-9150(99)00371-8","article-title":"Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery","volume":"150","author":"Pasterkamp","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0135","doi-asserted-by":"crossref","first-page":"12189","DOI":"10.1021\/bi970258a","article-title":"Oxidation of low-density lipoprotein by hemoglobin stems from a heme-initiated globin radical: antioxidant role of haptoglobin","volume":"36","author":"Miller","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0140","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1021\/bi0362626","article-title":"Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL","volume":"43","author":"Bamm","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0145","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1182\/blood.V98.13.3693","article-title":"Structure\u2013function analysis of the antioxidant properties of haptoglobin","volume":"98","author":"Melamed-Frank","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0150","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1161\/01.RES.0000251741.65179.56","article-title":"Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo","volume":"99","author":"Asleh","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0155","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/(SICI)1096-9896(199906)188:2<189::AID-PATH336>3.0.CO;2-N","article-title":"Local neovascularization and cellular composition within vulnerable regions of atherosclerotic plaques of human carotid arteries","volume":"188","author":"Jeziorska","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0160","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0735-1097(02)02534-2","article-title":"Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: the strong heart study","volume":"40","author":"Levy","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0165","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/diacare.26.9.2628","article-title":"Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes","volume":"26","author":"Roguin","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0170","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/ATVBAHA.107.153965","article-title":"Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial","volume":"28","author":"Milman","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0175","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.2337\/db08-0095","article-title":"Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes","volume":"57","author":"Costacou","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0180","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.2337\/diabetes.54.9.2802","article-title":"Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction","volume":"54","author":"Suleiman","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0185","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.2337\/diacare.27.11.2767","article-title":"The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes","volume":"27","author":"Levy","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0190","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0195","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/1358863X08092102","article-title":"Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART)","volume":"13","author":"Held","year":"2008","journal-title":"Vasc Med"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0200","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0741-5214(99)70053-4","article-title":"Folic acid inhibits homocysteine-induced proliferation of human arterial smooth muscle cells","volume":"30","author":"Carmody","year":"1999","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0205","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1160\/TH05-05-0313","article-title":"Homocysteine and thrombosis: from basic science to clinical evidence","volume":"94","author":"Undas","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0210","doi-asserted-by":"crossref","first-page":"872","DOI":"10.5858\/2007-131-872-HATAO","article-title":"Hyperhomocysteinemia and thrombosis: an overview","volume":"131","author":"Eldibany","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.atherosclerosis.2011.01.028_bib0215","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/ajcn\/67.2.263","article-title":"Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland homocysteine study","volume":"67","author":"Nygard","year":"1998","journal-title":"Am J Clin Nutr"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501100089X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501100089X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T03:47:36Z","timestamp":1637207256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191501100089X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S002191501100089X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.01.028","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}